Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-4-25
pubmed:abstractText
Suplatast tosilate (IPD) is a newly developed 'anti-allergic' drug. It seems to be a unique compound because of its ability to suppress IgE but not IgG or IgM production in vivo and cytokine production from type 2 helper T cells (Th2) in vitro. However, information on its in vivo effect on an animal model of asthma is limited.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1018-2438
pubmed:author
pubmed:copyrightInfo
Copyright 2000 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
116-22
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:10705221-Animals, pubmed-meshheading:10705221-Anti-Allergic Agents, pubmed-meshheading:10705221-Arylsulfonates, pubmed-meshheading:10705221-Asthma, pubmed-meshheading:10705221-Bronchial Hyperreactivity, pubmed-meshheading:10705221-Bronchial Provocation Tests, pubmed-meshheading:10705221-Bronchoalveolar Lavage Fluid, pubmed-meshheading:10705221-Cytokines, pubmed-meshheading:10705221-Disease Models, Animal, pubmed-meshheading:10705221-Eosinophilia, pubmed-meshheading:10705221-Female, pubmed-meshheading:10705221-Immunoglobulin E, pubmed-meshheading:10705221-Immunoglobulin G, pubmed-meshheading:10705221-Lung, pubmed-meshheading:10705221-Methacholine Chloride, pubmed-meshheading:10705221-Mice, pubmed-meshheading:10705221-Ovalbumin, pubmed-meshheading:10705221-Sulfonium Compounds
pubmed:year
2000
pubmed:articleTitle
Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
pubmed:affiliation
Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan.
pubmed:publicationType
Journal Article